HK1052636A1 - Use of an aqueous solution for the treatment of dry eye - Google Patents

Use of an aqueous solution for the treatment of dry eye

Info

Publication number
HK1052636A1
HK1052636A1 HK03103781A HK03103781A HK1052636A1 HK 1052636 A1 HK1052636 A1 HK 1052636A1 HK 03103781 A HK03103781 A HK 03103781A HK 03103781 A HK03103781 A HK 03103781A HK 1052636 A1 HK1052636 A1 HK 1052636A1
Authority
HK
Hong Kong
Prior art keywords
dry eye
treatment
aqueous solution
eyedrops
instilling
Prior art date
Application number
HK03103781A
Other languages
English (en)
Inventor
Frank Denick Jr
David J Heiler
Zhenze Hu
Joseph C Salamone
Richard V Smerbeck
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of HK1052636A1 publication Critical patent/HK1052636A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
HK03103781A 2000-04-04 2003-05-27 Use of an aqueous solution for the treatment of dry eye HK1052636A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/542,332 US6348508B1 (en) 2000-04-04 2000-04-04 Method for treating dry eye
PCT/US2001/009764 WO2001074330A2 (en) 2000-04-04 2001-03-27 Method for treating dry eye

Publications (1)

Publication Number Publication Date
HK1052636A1 true HK1052636A1 (en) 2003-09-26

Family

ID=24163356

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03103781A HK1052636A1 (en) 2000-04-04 2003-05-27 Use of an aqueous solution for the treatment of dry eye

Country Status (12)

Country Link
US (1) US6348508B1 (xx)
EP (1) EP1267827B8 (xx)
JP (1) JP2003528906A (xx)
CN (1) CN1279891C (xx)
AT (1) ATE316780T1 (xx)
AU (1) AU2001247822A1 (xx)
CA (1) CA2403869C (xx)
DE (1) DE60117009T2 (xx)
ES (1) ES2257403T3 (xx)
HK (1) HK1052636A1 (xx)
MX (1) MXPA02009826A (xx)
WO (1) WO2001074330A2 (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306123B1 (it) * 1999-04-02 2001-05-30 Technopharma Sa Soluzione oftalmica viscosizzata con azione detergente sulle lenti acontatto.
ES2259029T3 (es) * 2000-05-02 2006-09-16 BAUSCH & LOMB INCORPORATED Utilizacion de composiciones oftalmicas de concentracion ionica debil.
DE10161149B4 (de) * 2001-12-12 2007-03-08 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Heparin-haltigem Ophthalmikum
GB0130603D0 (en) * 2001-12-20 2002-02-06 Renaissance Healthcare Europ L Improvements in or relating to ophthalmic solutions
MXPA05000186A (es) * 2002-07-03 2005-08-17 Pericor Science Inc Composiciones de acido hialuronico y metodos de uso.
US6806364B2 (en) * 2002-07-29 2004-10-19 Ast Products, Inc. Ophthalmic compositions
US6828356B2 (en) * 2002-07-29 2004-12-07 Ast Products, Inc. Preparation of ophthalmic compositions
US20060172972A1 (en) * 2002-12-20 2006-08-03 Chakshu Research Inc Formulation and method for administration of ophthalmologically active agents
EP1972344A1 (en) 2002-12-20 2008-09-24 Chakshu Research, Inc. Ophthalmic formulation for the prevention and treatment of ocular conditions
US20060166879A1 (en) * 2002-12-20 2006-07-27 Chakshu Research Inc Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
US20060177430A1 (en) * 2002-12-20 2006-08-10 Chakshu Research Inc Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
US6984628B2 (en) * 2003-07-15 2006-01-10 Allergan, Inc. Ophthalmic compositions comprising trefoil factor family peptides
US20050119221A1 (en) * 2003-12-01 2005-06-02 Erning Xia Use of a cationic polysaccharide to enhance biocidal efficacies
JP5272307B2 (ja) * 2004-07-16 2013-08-28 大正製薬株式会社 水性点眼剤
WO2006038080A2 (en) * 2004-10-01 2006-04-13 Clearlab International Pte. Ltd. Contact lens package solution
US20060276359A1 (en) * 2005-06-03 2006-12-07 Bausch & Lomb Incorporated Composition and method for cleaning lipid deposits on contact lenses
US20060275173A1 (en) * 2005-06-03 2006-12-07 Bausch & Lomb Incorporated Method for cleaning lipid deposits on silicone hydrogel contact lenses
US20060292189A1 (en) * 2005-06-03 2006-12-28 Bausch & Lomb Incorporated Ophthalmic solution with a flavoring agent as a dosing indicator and method for indicating dosage of an ophthalmic solution
US7282178B2 (en) * 2005-06-03 2007-10-16 Bausch & Lomb Incorporated Composition and method for cleaning lipid deposits on contact lenses
IL169525A (en) * 2005-07-04 2008-12-29 Fischer Farmaceuticals Ltd Unstained sterile wipe and manufacturing process
CA2615231A1 (en) * 2005-07-15 2007-01-25 Chakshu Research Inc. Prevention and treatment of ophthalmic complications of diabetes
US20070116741A1 (en) * 2005-11-21 2007-05-24 Bausch & Lomb Incorporated Contact lenses with mucin affinity
US7988988B2 (en) * 2005-11-21 2011-08-02 Bausch & Lomb Incorporated Contact lenses with mucin affinity
US20070142321A1 (en) * 2005-12-21 2007-06-21 Roya Borazjani Method for preventing growth of bacteria on contact lenses with eye drops
US20070207116A1 (en) * 2006-03-01 2007-09-06 Brown David C Antioxidant compositions for the eye
US20120122815A1 (en) * 2006-03-28 2012-05-17 Erning Xia Composition for Treating Dry Eye and Related Methods of Manufacture and Methods of Use
US7832856B2 (en) * 2006-12-20 2010-11-16 Bausch & Lomb Incorporated Coatings and solutions for contact lenses
US20080151181A1 (en) * 2006-12-20 2008-06-26 Bausch & Lomb Incorporated Coatings and Solutions for Contact Lenses
EP2033974A1 (en) * 2007-09-06 2009-03-11 The Queens University of Belfast Conversion method
US20090142292A1 (en) * 2007-12-03 2009-06-04 Blackwell Richard I Method For The Mitigation of Symptoms of Dry Eye
US20100086512A1 (en) * 2008-10-02 2010-04-08 Rolf Schaefer Mucomimetic compositions and uses therefore
WO2013166459A1 (en) 2012-05-03 2013-11-07 Rajiv Bhushan Treating inflammatory conditions and improving oral hygiene using metal modulators with methylsulfonylmethane as transport enhancer
JP5988855B2 (ja) * 2012-06-27 2016-09-07 ロート製薬株式会社 水性眼科組成物
US9463201B2 (en) 2014-10-19 2016-10-11 M.G. Therapeutics Ltd Compositions and methods for the treatment of meibomian gland dysfunction
EP3313413A4 (en) 2015-09-28 2018-07-11 Azura Opthalmics Ltd. Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion
WO2017178892A2 (en) 2016-04-14 2017-10-19 M.G. Therapeutics Ltd. Selenium disulfide compositions for use in treating meibomian gland dysfunction
US20220054520A1 (en) * 2019-02-27 2022-02-24 Santen Pharmaceutical Co., Ltd. Ophthalmic composition containing diquafosol or salt thereof, vinyl-based polymer and cellulose-based polymer
WO2021140417A2 (en) 2020-01-10 2021-07-15 Azura Ophthalmics Ltd. Instructions for composition and sensitivity
CN116473017B (zh) * 2023-03-22 2024-01-05 首都医科大学附属北京同仁医院 基于小鼠泪腺诱导的干燥综合征小鼠模型的造模方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409205A (en) 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4436730A (en) 1979-06-25 1984-03-13 Polymer Technology Corporation Ionic opthalmic cellulose polymer solutions
US4388781A (en) 1981-09-21 1983-06-21 The Gleason Works Rotary tool for straddle grinding
DE3440352A1 (de) 1984-11-05 1986-05-07 Dr. Thilo & Co GmbH, 8029 Sauerlach Dry-eye-packung
US5209927A (en) 1985-01-23 1993-05-11 Alcon Laboratories, Inc. Ophthalmic solution
ATE132366T1 (de) 1990-05-29 1996-01-15 Boston Ocular Res Zusammensetzung zur behandlung von dry eye erkrankungen
US5645827A (en) 1992-09-30 1997-07-08 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5358706A (en) * 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5401327A (en) 1993-06-18 1995-03-28 Wilmington Partners L.P. Method of treating contact lenses
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
US6274133B1 (en) * 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Method for treating extended-wear contact lenses in the eyes
US6037328A (en) * 1998-12-22 2000-03-14 Bausch & Lomb Incorporated Method and composition for rewetting and preventing deposits on contact lens
WO2000054747A2 (en) * 1999-03-18 2000-09-21 Bausch & Lomb Incorporated Method for treating dry eye

Also Published As

Publication number Publication date
JP2003528906A (ja) 2003-09-30
CN1279891C (zh) 2006-10-18
WO2001074330A3 (en) 2002-06-27
WO2001074330A2 (en) 2001-10-11
EP1267827B8 (en) 2007-01-10
CN1422148A (zh) 2003-06-04
DE60117009T2 (de) 2006-08-03
MXPA02009826A (es) 2003-03-27
DE60117009D1 (de) 2006-04-13
ES2257403T3 (es) 2006-08-01
AU2001247822A1 (en) 2001-10-15
EP1267827A2 (en) 2003-01-02
US6348508B1 (en) 2002-02-19
EP1267827B1 (en) 2006-02-01
ATE316780T1 (de) 2006-02-15
CA2403869C (en) 2007-04-10
CA2403869A1 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
HK1052636A1 (en) Use of an aqueous solution for the treatment of dry eye
AU2002322298A1 (en) Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
MX2009005836A (es) Preparaciones antimicrobianas sinergisticas que contienen clorito y peroxido de hidrogeno.
BR9914109A (pt) Composições antibióticas para tratamento dos olhos, ouvidos e nariz
NO964361D0 (no) Fiberbehandling
BR9914151A (pt) Composições antibióticas para tratamento dos olhos, ouvidos e nariz
TW366285B (en) Composition for treating psoriasis
DE60101265D1 (de) Behandlung von augenschmerzen
KR900015722A (ko) N-(3,4-디메톡시신나모일) 안트라닐산을 함유하는 약제 조성물
ATE291917T1 (de) Topisch anzuwendende ketoconazol enthaltende emulsionen
BR0314163A (pt) Composições para o traramento de superfìcies rìgidas
ATA150990A (de) Loesung von cellulose in wasser und n-methyl-morpholin-n-oxid
BR0111510A (pt) Processo de tratamento de tecidos com um tablete de detergente compreendendo uma resina de permuta de ìon
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
ES2026314A6 (es) Procedimiento para obtener una composicion profilactica antimicrobiana oftalmica neonatal.
ATE53489T1 (de) Zusammensetzung zur behandlung von hauterkrankungen und ihre verwendung.
ATE383852T1 (de) Kupferchelatbildner zur behandlung von augenentzündungen
AU5521001A (en) Low ionic strength ophthalmic compositions
ATE359774T1 (de) Taurinderivate verwendbar in der behandlung von netzhauterkrankungen
WO2002098843A3 (en) Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors
WO2000054747A3 (en) Method for treating dry eye
HUP9801925A1 (hu) Nátrium/hidrogén-csere inhibítorok alkalmazása protozoák által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
HK1043739A1 (en) Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa.
PT1251826E (pt) Gel de suspensao de ciclofenamida
CN102973431A (zh) 一种含升华硫与水杨酸的洗发液及其制备方法

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100327